Blocknomi
Key Highlights Shares of Can-Fite BioPharma (CANF) climbed as high as 65% on Wednesday following the release of Phase 2a clinical data for Namodenoson in patients with advanced pancreatic cancer.…
Related articles
-
Alibaba (BABA) Stock Soars 11% as Pre-Earnings Briefing Sparks Chinese Tech Rally
Blocknomi Published 08.07.2026 10:20
-
Robinhood’s Tenev: Real-World Assets Will Drive Crypto’s Next Chapter, Not Memecoins
Blocknomi Published 03.07.2026 07:43
-
Coinbase CEO Armstrong Comments on Betting Promotion Concerns in the Base App
BeInCrypto Published 28.06.2026 12:01
-
Venice (VVV) price prediction: AI token to $21?
Crypto.News Published 02.07.2026 22:02
-
Bithumb fined as South Korea cracks down on crypto user data
Crypto.News Published 25.06.2026 08:35
-
SanDisk (SNDK) Stock Plunges 12% While Bernstein Raises Target to $3,000
Blocknomi Published 30.06.2026 09:55
-
Apple’s Foldable iPhone Rumor Turns Hardware Back Into a Momentum Trade
Crypto Daily Published 03.07.2026 12:01
-
Quantum Cyber (QUCY) Shares Jump 32% on SpaceX Investment Plans
Blocknomi Published 26.06.2026 14:41